Medication Adjustments for Weight Gain and Menstrual Irregularity

Immediate Medication Changes to Address Weight Gain

The American Academy of Child and Adolescent Psychiatry recommends switching from mirtazapine to an alternative antidepressant, such as bupropion, which is associated with weight loss, and considering switching from Abilify to a more weight-neutral antipsychotic, as mirtazapine is strongly associated with weight gain and appetite increase, while Abilify carries moderate metabolic risk 1, 2
Discontinue mirtazapine, even at low doses, as it is consistently associated with increased appetite and significant weight gain through its antagonism of H1 receptors and 5-HT2/5-HT3 receptors 2
Replace mirtazapine with bupropion, which is the only antidepressant consistently shown to promote weight loss through appetite suppression and reduced food cravings, but assess anxiety levels carefully before prescribing bupropion, as it is activating and may exacerbate anxiety 2, 3, 4
If anxiety is significant, consider fluoxetine or sertraline instead, which are associated with initial weight loss and long-term weight neutrality 2, 4
Consider switching to lurasidone or ziprasidone, which are the most weight-neutral atypical antipsychotics, but this switch should only occur if bipolar symptoms are well-controlled and after careful discussion of risks versus benefits 1, 2, 3

Initiate metformin 500mg once daily, gradually increasing to 1000mg twice daily as tolerated, to attenuate antipsychotic-associated weight gain, and use modified-release preparations when available to minimize gastrointestinal side effects 3
Check baseline renal function before starting metformin, as it is contraindicated in renal failure, and monitor annually: liver function, HbA1c, renal function, and vitamin B12 3
Obtain baseline measurements: BMI, waist circumference, blood pressure, fasting glucose, fasting lipid panel, HbA1c, prolactin, liver function tests, and monitor BMI monthly for 3 months, then quarterly 1, 3, 5
Recheck fasting glucose after 4 weeks of any antipsychotic adjustment, and repeat all baseline measurements after 3 months and annually thereafter 3

Check prolactin levels immediately, as antipsychotics can cause hyperprolactinemia leading to menstrual irregularity, and rule out valproate use, as it is associated with polycystic ovary disease in females 1, 6

Implement dietary counseling and structured physical activity program at treatment initiation, and these interventions should be concurrent with medication changes, not sequential 3, 5

The regimen that stabilized acute mania should be maintained for 12-24 months to prevent relapse, and any medication discontinuation must be gradual with close monitoring for mood episode recurrence 1
Educate patient and family about early signs of manic or depressive episodes 1

Do not attribute all menstrual irregularity to weight gain alone—check prolactin levels and assess for PCOS, and do not switch antipsychotics without ensuring bipolar stability, as maintaining mood stabilization takes priority over metabolic concerns in the acute phase 1
Do not overlook the cumulative metabolic burden of multiple medications, even at low doses, and do not delay metformin initiation while waiting for other interventions to work, as it can be started concomitantly with antipsychotics 1, 2, 3